Lien Gheyle

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Erik S.G. Stroes, John R. Guyton, Norman E. Lepor et al. · Journal of the American Heart Association · 2016 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

The NK3 Receptor Antagonist ESN364 Suppresses Sex Hormones in Men and Women

Graeme L. Fraser, Steven Ramael, Hamid R. Hoveyda et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 79 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Wivine Burny, Arnaud Marchant, Caroline Hervé et al. · Vaccine · 2019 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects

Christopher Wynne, Mario Altendorfer, Ivo Sonderegger et al. · Expert Opinion on Investigational Drugs · 2016 · 59 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral <scp>PDE9A</scp> inhibitor <scp>BI</scp> 409306 in healthy male volunteers

Katja Boland, Viktoria Moschetti, C. Dansirikul et al. · Human Psychopharmacology Clinical and Experimental · 2017 · 29 citations

Medicine, Pharmacokinetics, Pharmacology +15